FTO enhances gene mediated cell transformation and leukemogenesis and inhibits AML cell differentiation by downregulating m6A levels in mRNA transcripts and regulating the expression of targets such as RARA and ASB2 [9]. This evidence concerns the gene RARA and acute myeloid leukemia.